[Primary prevention of cardiovascular diseases with statins in women].
Cardiovascular disease is one of the leading causes of mortality and morbidity in postmenopausal women. Menopausal changes have been shown to be related with an atherogenic lipid profile. The efficiency of statins in reducing the incidence of cardiovascular diseases has been well-documented in a variety of randomized, placebo-controlled trials. This review outlines the effectiveness of statins both in cardiac events and in some noticeable indications in postmenopausal women.
Alici
Gökhan
G
Department of Cardiology, Cerrahpaşa Medicine Faculty of Istanbul University, Istanbul, Turkey. gokhanalici@yahoo.com
Karpuz
Vildan
V
Karpuz
Hakan
H
D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D017698:Postmenopause; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors